speb/financial-data huggingface dataset:
BLDR balance_sheet (annual, 2023-12-31) — Current Liabilities: 1863437000.00
BLDR balance_sheet (annual, 2023-12-31) — Current Provisions: 89987000.00
BLDR cash_flow (annual, 2023-12-31) — Deferred Income Tax: -102461000.00
BLDR cash_flow (annual, 2023-12-31) — Deferred Tax: -102461000.00
BLDR cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 558275000.00
BLDR cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 558275000.00
BLDR income_statement (annual, 2023-12-31) — Diluted Average Shares: 128998000.00
BLDR income_statement (annual, 2023-12-31) — Diluted EPS: 11.94
BLDR income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 1540555000.00
BLDR income_statement (annual, 2023-12-31) — EBIT: 2176319000.00
BLDR income_statement (annual, 2023-12-31) — EBITDA: 2734594000.00
BLDR cash_flow (annual, 2023-12-31) — End Cash Position: 66156000.00
BLDR cash_flow (annual, 2023-12-31) — Financing Cash Flow: -1652868000.00
BLDR cash_flow (annual, 2023-12-31) — Free Cash Flow: 1830537000.00
BLDR balance_sheet (annual, 2023-12-31) — Goodwill: 3556556000.00
BLDR balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 4854729000.00
BLDR balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 1479405000.00
BLDR balance_sheet (annual, 2023-12-31) — Gross PPE: 3317997000.00
BLDR income_statement (annual, 2023-12-31) — Gross Profit: 6012334000.00
BLDR cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 578734000.00
BLDR income_statement (annual, 2023-12-31) — Interest Expense: 192115000.00
BLDR income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 192115000.00
BLDR cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 186497000.00
BLDR balance_sheet (annual, 2023-12-31) — Interest Payable: 34537000.00
BLDR balance_sheet (annual, 2023-12-31) — Inventory: 1228265000.00
BLDR balance_sheet (annual, 2023-12-31) — Invested Capital: 7913411000.00
BLDR cash_flow (annual, 2023-12-31) — Investing Cash Flow: -668293000.00
BLDR cash_flow (annual, 2023-12-31) — Issuance Of Debt: 5128000000.00
BLDR balance_sheet (annual, 2023-12-31) — Land And Improvements: 369574000.00
BLDR balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 434081000.00
BLDR balance_sheet (annual, 2023-12-31) — Long Term Debt: 3177411000.00
BLDR balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 3611492000.00
BLDR cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 5128000000.00
BLDR cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -4932221000.00
BLDR balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 1516378000.00
BLDR cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -238673000.00
BLDR cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -1811517000.00
BLDR balance_sheet (annual, 2023-12-31) — Net Debt: 3114904000.00
BLDR income_statement (annual, 2023-12-31) — Net Income: 1540555000.00
BLDR income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 1540555000.00
BLDR income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 1540555000.00
BLDR income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 1540555000.00
BLDR income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 1540555000.00
BLDR cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 1540555000.00
BLDR income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 1540555000.00
BLDR income_statement (annual, 2023-12-31) — Net Interest Income: -192115000.00
BLDR cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 195779000.00
BLDR cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 195779000.00
BLDR income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -192115000.00
BLDR cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -37130000.00
BLDR balance_sheet (annual, 2023-12-31) — Net PPE: 2306008000.00
BLDR cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -429620000.00
BLDR balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -122378000.00
BLDR balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 167199000.00
BLDR balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 167199000.00
BLDR income_statement (annual, 2023-12-31) — Normalized EBITDA: 2734594000.00
BLDR income_statement (annual, 2023-12-31) — Normalized Income: 1540555000.00
BLDR cash_flow (annual, 2023-12-31) — Operating Cash Flow: 2306872000.00
BLDR cash_flow (annual, 2023-12-31) — Operating Gains Losses: -6344000.00
BLDR income_statement (annual, 2023-12-31) — Operating Income: 2176319000.00
BLDR income_statement (annual, 2023-12-31) — Operating Revenue: 17097330000.00
BLDR balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 121857000.00
BLDR balance_sheet (annual, 2023-12-31) — Other Current Assets: 113403000.00
BLDR balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 3649000.00
BLDR balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 1298173000.00
BLDR cash_flow (annual, 2023-12-31) — Other Non Cash Items: -1659000.00
BLDR balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 37987000.00
BLDR balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 124973000.00
BLDR balance_sheet (annual, 2023-12-31) — Other Properties: 509452000.00
BLDR balance_sheet (annual, 2023-12-31) — Other Receivables: 455987000.00
BLDR balance_sheet (annual, 2023-12-31) — Payables: 957482000.00
BLDR balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 1508925000.00
BLDR balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
BLDR income_statement (annual, 2023-12-31) — Pretax Income: 1984204000.00
BLDR cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 659000.00
BLDR balance_sheet (annual, 2023-12-31) — Properties: 0.00
BLDR cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: -11488000.00
BLDR cash_flow (annual, 2023-12-31) — Purchase Of Business: -238673000.00
BLDR cash_flow (annual, 2023-12-31) — Purchase Of PPE: -476335000.00
BLDR balance_sheet (annual, 2023-12-31) — Receivables: 1892904000.00
BLDR income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 11084996000.00
BLDR income_statement (annual, 2023-12-31) — Reconciled Depreciation: 558275000.00
BLDR cash_flow (annual, 2023-12-31) — Repayment Of Debt: -4932221000.00
BLDR cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -1811517000.00
BLDR balance_sheet (annual, 2023-12-31) — Retained Earnings: 460184000.00
BLDR cash_flow (annual, 2023-12-31) — Sale Of Business: 0.00
BLDR cash_flow (annual, 2023-12-31) — Sale Of PPE: 46715000.00
BLDR income_statement (annual, 2023-12-31) — Selling General And Administration: 3836015000.00
BLDR balance_sheet (annual, 2023-12-31) — Share Issued: 121857000.00
BLDR cash_flow (annual, 2023-12-31) — Stock Based Compensation: 48522000.00
BLDR balance_sheet (annual, 2023-12-31) — Stockholders Equity: 4732351000.00
BLDR balance_sheet (annual, 2023-12-31) — Tangible Book Value: -122378000.00
BLDR income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
BLDR income_statement (annual, 2023-12-31) — Tax Provision: 443649000.00
BLDR income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.22
BLDR balance_sheet (annual, 2023-12-31) — Total Assets: 10499452000.00
BLDR balance_sheet (annual, 2023-12-31) — Total Capitalization: 7909762000.00
BLDR balance_sheet (annual, 2023-12-31) — Total Debt: 3713358000.00
BLDR balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 4732351000.00
BLDR income_statement (annual, 2023-12-31) — Total Expenses: 14921011000.00
BLDR balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 5767101000.00
BLDR balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 7198724000.00
BLDR balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 3903664000.00
BLDR income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 2176319000.00
BLDR balance_sheet (annual, 2023-12-31) — Total Tax Payable: 76098000.00
BLDR balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
BLDR balance_sheet (annual, 2023-12-31) — Working Capital: 1437291000.00
BLDR income_statement (annual, 2024-12-31) — +Operating Expense: 3787795000.00
BLDR income_statement (annual, 2024-12-31) — +Total Revenue: 16400492000.00
BLDR balance_sheet (annual, 2024-12-31) — Accounts Payable: 868054000.00
BLDR balance_sheet (annual, 2024-12-31) — Accounts Receivable: 1163147000.00
BLDR balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -1205973000.00
BLDR balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -1205973000.00
BLDR balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 4271269000.00
BLDR balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -41233000.00
BLDR income_statement (annual, 2024-12-31) — Basic Average Shares: 118038000.00
BLDR income_statement (quarterly, 2024-12-31) — Basic Average Shares: 114814000.00
BLDR income_statement (annual, 2024-12-31) — Basic EPS: 9.13
BLDR cash_flow (annual, 2024-12-31) — Beginning Cash Position: 66156000.00
BLDR balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 834773000.00
BLDR balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 834773000.00
BLDR cash_flow (annual, 2024-12-31) — Capital Expenditure: -380569000.00
BLDR balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 628712000.00
BLDR balance_sheet (annual, 2024-12-31) — Capital Stock: 1136000.00
BLDR balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 153624000.00
BLDR balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 153624000.00
BLDR cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -1074505000.00
BLDR cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -710719000.00
BLDR cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 1872692000.00
BLDR cash_flow (annual, 2024-12-31) — Change In Account Payable: -28600000.00
BLDR cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -78350000.00
BLDR cash_flow (annual, 2024-12-31) — Change In Inventory: 51475000.00
BLDR cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -2828000.00
BLDR cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -50125000.00
BLDR cash_flow (annual, 2024-12-31) — Change In Payable: -28600000.00
BLDR cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -106950000.00
BLDR cash_flow (annual, 2024-12-31) — Change In Receivables: 274652000.00
BLDR cash_flow (annual, 2024-12-31) — Change In Working Capital: 166224000.00
BLDR cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 259616000.00
BLDR cash_flow (annual, 2024-12-31) — Changes In Cash: 87468000.00
BLDR balance_sheet (annual, 2024-12-31) — Common Stock: 1136000.00
BLDR balance_sheet (annual, 2024-12-31) — Common Stock Equity: 4296470000.00
BLDR cash_flow (annual, 2024-12-31) — Common Stock Payments: -1517131000.00
BLDR balance_sheet (annual, 2024-12-31) — Construction In Progress: 141864000.00
BLDR balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 141864000.00
BLDR income_statement (annual, 2024-12-31) — Cost Of Revenue: 11017448000.00
BLDR balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 458225000.00
BLDR balance_sheet (annual, 2024-12-31) — Current Assets: 3141239000.00
BLDR balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 103499000.00
BLDR balance_sheet (annual, 2024-12-31) — Current Debt: 3470000.00
BLDR balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 106969000.00
BLDR balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 168208000.00
BLDR balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 168208000.00
BLDR balance_sheet (annual, 2024-12-31) — Current Liabilities: 1777276000.00
BLDR balance_sheet (annual, 2024-12-31) — Current Provisions: 102876000.00
BLDR cash_flow (annual, 2024-12-31) — Deferred Income Tax: -19033000.00
BLDR cash_flow (annual, 2024-12-31) — Deferred Tax: -19033000.00
BLDR cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 561929000.00
BLDR cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 561929000.00
BLDR income_statement (annual, 2024-12-31) — Diluted Average Shares: 118980000.00
BLDR income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 115598000.00
BLDR income_statement (annual, 2024-12-31) — Diluted EPS: 9.06
BLDR income_statement (quarterly, 2024-12-31) — Diluted EPS: 1.65
BLDR income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 1077898000.00
BLDR income_statement (annual, 2024-12-31) — EBIT: 1595249000.00
BLDR income_statement (annual, 2024-12-31) — EBITDA: 2157178000.00
BLDR cash_flow (annual, 2024-12-31) — End Cash Position: 153624000.00
BLDR cash_flow (annual, 2024-12-31) — Financing Cash Flow: -1074505000.00
BLDR cash_flow (annual, 2024-12-31) — Free Cash Flow: 1492123000.00
BLDR balance_sheet (annual, 2024-12-31) — Goodwill: 3678504000.00
BLDR balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 4782138000.00
BLDR balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 1204380000.00
BLDR balance_sheet (annual, 2024-12-31) — Gross PPE: 3762005000.00
BLDR income_statement (annual, 2024-12-31) — Gross Profit: 5383044000.00
BLDR cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 373059000.00
BLDR income_statement (annual, 2024-12-31) — Interest Expense: 207724000.00
BLDR income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 207724000.00
BLDR cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 188453000.00
BLDR balance_sheet (annual, 2024-12-31) — Interest Payable: 55454000.00
BLDR balance_sheet (annual, 2024-12-31) — Inventory: 1212375000.00
BLDR balance_sheet (annual, 2024-12-31) — Invested Capital: 8000583000.00
BLDR cash_flow (annual, 2024-12-31) — Investing Cash Flow: -710719000.00
BLDR cash_flow (annual, 2024-12-31) — Issuance Of Debt: 1954000000.00
BLDR balance_sheet (annual, 2024-12-31) — Land And Improvements: 401374000.00
BLDR balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 401374000.00
BLDR balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 525213000.00
BLDR balance_sheet (annual, 2024-12-31) — Long Term Debt: 3700643000.00
BLDR balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 4225856000.00
BLDR cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 1954000000.00
BLDR cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -1421397000.00
BLDR balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 1786214000.00
BLDR balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 1786214000.00
BLDR cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -344144000.00
BLDR cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -1517131000.00
BLDR balance_sheet (annual, 2024-12-31) — Net Debt: 3550489000.00
BLDR income_statement (annual, 2024-12-31) — Net Income: 1077898000.00
BLDR income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 1077898000.00
BLDR income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 1077898000.00
BLDR income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 1077898000.00
BLDR income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 1077898000.00
BLDR cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 1077898000.00
BLDR income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 1077898000.00
BLDR income_statement (annual, 2024-12-31) — Net Interest Income: -207724000.00
BLDR cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 532603000.00
BLDR cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 532603000.00
BLDR income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -207724000.00
BLDR cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -89977000.00
BLDR balance_sheet (annual, 2024-12-31) — Net PPE: 2556032000.00
BLDR cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -366575000.00
BLDR balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -485668000.00
BLDR balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 0.00
BLDR balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Assets: 0.00
BLDR balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 148167000.00
BLDR balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 0.00
BLDR balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Assets: 0.00
BLDR balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 148167000.00
BLDR income_statement (annual, 2024-12-31) — Normalized EBITDA: 2157178000.00
BLDR income_statement (annual, 2024-12-31) — Normalized Income: 1077898000.00
BLDR cash_flow (annual, 2024-12-31) — Operating Cash Flow: 1872692000.00
BLDR cash_flow (annual, 2024-12-31) — Operating Gains Losses: 16972000.00
BLDR income_statement (annual, 2024-12-31) — Operating Income: 1595249000.00
BLDR income_statement (annual, 2024-12-31) — Operating Revenue: 16400492000.00
BLDR balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 113578000.00
BLDR balance_sheet (annual, 2024-12-31) — Other Current Assets: 116656000.00
BLDR balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 3470000.00
BLDR balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 1103634000.00
BLDR cash_flow (annual, 2024-12-31) — Other Non Cash Items: 22563000.00
BLDR balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 103677000.00
BLDR balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 135317000.00
BLDR balance_sheet (annual, 2024-12-31) — Other Properties: 597780000.00
BLDR balance_sheet (annual, 2024-12-31) — Other Receivables: 495437000.00
BLDR balance_sheet (annual, 2024-12-31) — Payables: 940998000.00
BLDR balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 1399223000.00
BLDR balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
BLDR income_statement (annual, 2024-12-31) — Pretax Income: 1387525000.00
BLDR balance_sheet (annual, 2024-12-31) — Properties: 0.00
BLDR balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
BLDR cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 10419000.00
BLDR cash_flow (annual, 2024-12-31) — Purchase Of Business: -344144000.00
BLDR cash_flow (annual, 2024-12-31) — Purchase Of PPE: -380569000.00
BLDR balance_sheet (annual, 2024-12-31) — Receivables: 1658584000.00
BLDR income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 11017448000.00
BLDR income_statement (annual, 2024-12-31) — Reconciled Depreciation: 561929000.00
BLDR cash_flow (annual, 2024-12-31) — Repayment Of Debt: -1421397000.00
BLDR cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -1517131000.00
BLDR balance_sheet (annual, 2024-12-31) — Retained Earnings: 24065000.00
BLDR cash_flow (annual, 2024-12-31) — Sale Of PPE: 13994000.00
BLDR income_statement (annual, 2024-12-31) — Selling General And Administration: 3787795000.00
BLDR balance_sheet (annual, 2024-12-31) — Share Issued: 113578000.00
BLDR cash_flow (annual, 2024-12-31) — Stock Based Compensation: 63111000.00
BLDR balance_sheet (annual, 2024-12-31) — Stockholders Equity: 4296470000.00
BLDR balance_sheet (annual, 2024-12-31) — Tangible Book Value: -485668000.00
BLDR income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
BLDR income_statement (annual, 2024-12-31) — Tax Provision: 309627000.00
BLDR income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.22
BLDR balance_sheet (annual, 2024-12-31) — Total Assets: 10583086000.00
BLDR balance_sheet (annual, 2024-12-31) — Total Capitalization: 7997113000.00
BLDR balance_sheet (annual, 2024-12-31) — Total Debt: 4332825000.00
BLDR balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 4296470000.00
BLDR income_statement (annual, 2024-12-31) — Total Expenses: 14805243000.00
BLDR balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 6286616000.00
BLDR balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 7441847000.00
BLDR balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 4509340000.00
BLDR income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 1595249000.00
BLDR balance_sheet (annual, 2024-12-31) — Total Tax Payable: 72944000.00
BLDR balance_sheet (annual, 2024-12-31) — Working Capital: 1363963000.00
BLDR income_statement (quarterly, 2025-03-31) — +Operating Expense: 930800000.00
BLDR income_statement (quarterly, 2025-03-31) — +Total Revenue: 3657496000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1022022000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 1251571000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 4265403000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -44993000.00
BLDR income_statement (quarterly, 2025-03-31) — Basic Average Shares: 113675000.00
BLDR income_statement (quarterly, 2025-03-31) — Basic EPS: 0.85
BLDR cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 153624000.00
BLDR cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -99974000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 629722000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Capital Stock: 1137000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 115371000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 115371000.00
BLDR cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 741475000.00
BLDR cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -912056000.00
BLDR cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 132328000.00
BLDR cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 142891000.00
BLDR cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -166294000.00
BLDR cash_flow (quarterly, 2025-03-31) — Change In Inventory: -82503000.00
BLDR cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -15013000.00
BLDR cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -4662000.00
BLDR cash_flow (quarterly, 2025-03-31) — Change In Payable: 142891000.00
BLDR cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -23403000.00
BLDR cash_flow (quarterly, 2025-03-31) — Change In Receivables: 19748000.00
BLDR cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -105833000.00
BLDR cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 30599000.00
BLDR cash_flow (quarterly, 2025-03-31) — Changes In Cash: -38253000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Common Stock: 1137000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 4374160000.00
BLDR cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -12347000.00
BLDR income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 2542255000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 296530000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Current Assets: 3280405000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 104045000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Current Debt: 7244000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 111289000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 184746000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 184746000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 1801456000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Current Provisions: 105421000.00
BLDR cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -10638000.00
BLDR cash_flow (quarterly, 2025-03-31) — Deferred Tax: -10638000.00
BLDR cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 145031000.00
BLDR cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 145031000.00
BLDR income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 114339000.00
BLDR income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.84
BLDR income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 96304000.00
BLDR income_statement (quarterly, 2025-03-31) — EBIT: 184441000.00
BLDR income_statement (quarterly, 2025-03-31) — EBITDA: 329472000.00
BLDR cash_flow (quarterly, 2025-03-31) — End Cash Position: 115371000.00
BLDR cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 741475000.00
BLDR cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 32354000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Goodwill: 3969019000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 5287316000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 1296564000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Gross PPE: 2768334000.00
BLDR income_statement (quarterly, 2025-03-31) — Gross Profit: 1115241000.00
BLDR cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 1856000.00
BLDR income_statement (quarterly, 2025-03-31) — Interest Expense: 64892000.00
BLDR income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 64892000.00
BLDR cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 88678000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Interest Payable: 30703000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Inventory: 1348909000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Invested Capital: 8853664000.00
BLDR cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -912056000.00
BLDR cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 1142000000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 525677000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 4472260000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 4997937000.00
BLDR cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 1142000000.00
BLDR cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -367754000.00
BLDR cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -824795000.00
BLDR cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -12347000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Net Debt: 4364133000.00
BLDR income_statement (quarterly, 2025-03-31) — Net Income: 96304000.00
BLDR income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 96304000.00
BLDR income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 96304000.00
BLDR income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 96304000.00
BLDR income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 96304000.00
BLDR cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 96304000.00
BLDR income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 96304000.00
BLDR income_statement (quarterly, 2025-03-31) — Net Interest Income: -64892000.00
BLDR cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 0.00
BLDR cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 774246000.00
BLDR cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 774246000.00
BLDR income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -64892000.00
BLDR cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -20424000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Net PPE: 2768334000.00
BLDR cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -87261000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -913156000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 137528000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 137528000.00
BLDR income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 329472000.00
BLDR income_statement (quarterly, 2025-03-31) — Normalized Income: 96304000.00
BLDR cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 132328000.00
BLDR income_statement (quarterly, 2025-03-31) — Operating Income: 184441000.00
BLDR income_statement (quarterly, 2025-03-31) — Operating Revenue: 3657496000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 113726000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 132390000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 7244000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 1318297000.00
BLDR cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -6774000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 111560000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 136534000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Other Properties: 2768334000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Other Receivables: 432164000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Payables: 1103470000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 1400000000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
BLDR income_statement (quarterly, 2025-03-31) — Pretax Income: 119549000.00
BLDR cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -824795000.00
BLDR cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: 0.00
BLDR cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -99974000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Receivables: 1683735000.00
BLDR income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 2542255000.00
BLDR income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 145031000.00
BLDR cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -367754000.00
BLDR cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -12347000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 107620000.00
BLDR cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 12713000.00
BLDR income_statement (quarterly, 2025-03-31) — Selling General And Administration: 930800000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Share Issued: 113726000.00
BLDR cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 14238000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 4374160000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -913156000.00
BLDR income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
BLDR income_statement (quarterly, 2025-03-31) — Tax Provision: 23245000.00
BLDR income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.19
BLDR balance_sheet (quarterly, 2025-03-31) — Total Assets: 11447615000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 8846420000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Total Debt: 5109226000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 4374160000.00
BLDR income_statement (quarterly, 2025-03-31) — Total Expenses: 3473055000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 7073455000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 8167210000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 5271999000.00
BLDR income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 184441000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 81448000.00
BLDR balance_sheet (quarterly, 2025-03-31) — Working Capital: 1478949000.00
BLDR income_statement (quarterly, 2025-06-30) — +Operating Expense: 987754000.00
BLDR income_statement (quarterly, 2025-06-30) — +Total Revenue: 4234064000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1008412000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 1331378000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 4176987000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -47479000.00
BLDR income_statement (quarterly, 2025-06-30) — Basic EPS: 1.67
BLDR cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 115371000.00
BLDR cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -88739000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 637465000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Capital Stock: 1105000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 87020000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 87020000.00
BLDR cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -221974000.00
BLDR cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -147417000.00
BLDR cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 341040000.00
BLDR cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -16271000.00
BLDR cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 50762000.00
BLDR cash_flow (quarterly, 2025-06-30) — Change In Inventory: 52034000.00
BLDR cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 1576000.00
BLDR cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -8516000.00
BLDR cash_flow (quarterly, 2025-06-30) — Change In Payable: -16271000.00
BLDR cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 34491000.00
BLDR cash_flow (quarterly, 2025-06-30) — Change In Receivables: -66594000.00
BLDR cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 12991000.00
BLDR cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -64537000.00
BLDR cash_flow (quarterly, 2025-06-30) — Changes In Cash: -28351000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Common Stock: 1105000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 4178092000.00
BLDR cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -401610000.00
BLDR income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 2935023000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 357078000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Current Assets: 3287617000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 106175000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Current Debt: 7063000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 113238000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 182604000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 182604000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 1834631000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Current Provisions: 101973000.00
BLDR cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -21729000.00
BLDR cash_flow (quarterly, 2025-06-30) — Deferred Tax: -21729000.00
BLDR cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 147524000.00
BLDR cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 147524000.00
BLDR income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 185031000.00
BLDR income_statement (quarterly, 2025-06-30) — EBIT: 311287000.00
BLDR income_statement (quarterly, 2025-06-30) — EBITDA: 458811000.00
BLDR cash_flow (quarterly, 2025-06-30) — End Cash Position: 87020000.00
BLDR cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -221974000.00
BLDR cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 252301000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Goodwill: 3988853000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 5251264000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 1378857000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Gross PPE: 2794978000.00
BLDR income_statement (quarterly, 2025-06-30) — Gross Profit: 1299041000.00
BLDR cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 60189000.00
BLDR income_statement (quarterly, 2025-06-30) — Interest Expense: 71988000.00
BLDR income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 71988000.00
BLDR cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 36655000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Interest Payable: 64261000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Inventory: 1309089000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Invested Capital: 8855138000.00
BLDR cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -147417000.00
BLDR cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 3431000000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 531290000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 4669983000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 5201273000.00
BLDR cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 3431000000.00
BLDR cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -3223696000.00
BLDR cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: -61397000.00
BLDR cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -401610000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Net Debt: 4590026000.00
BLDR income_statement (quarterly, 2025-06-30) — Net Income: 185031000.00
BLDR income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 185031000.00
BLDR income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 185031000.00
BLDR income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 185031000.00
BLDR income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 185031000.00
BLDR cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 185031000.00
BLDR income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 185031000.00
BLDR income_statement (quarterly, 2025-06-30) — Net Interest Income: -71988000.00
BLDR cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 207304000.00
BLDR cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 207304000.00
BLDR income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -71988000.00
BLDR cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -27668000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Net PPE: 2794978000.00
BLDR cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -86020000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -1073172000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 115799000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 115799000.00
BLDR income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 458811000.00
BLDR income_statement (quarterly, 2025-06-30) — Normalized Income: 185031000.00
BLDR cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 341040000.00
BLDR income_statement (quarterly, 2025-06-30) — Operating Income: 311287000.00
BLDR income_statement (quarterly, 2025-06-30) — Operating Revenue: 4234064000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 110537000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 130858000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 7063000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 1262411000.00
BLDR cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 1063000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 130696000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 134760000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Other Properties: 2794978000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Other Receivables: 429272000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Payables: 1079738000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 1436816000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
BLDR income_statement (quarterly, 2025-06-30) — Pretax Income: 239299000.00
BLDR cash_flow (quarterly, 2025-06-30) — Purchase Of Business: -61397000.00
BLDR cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -88739000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Receivables: 1760650000.00
BLDR income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 2935023000.00
BLDR income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 147524000.00
BLDR cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -3223696000.00
BLDR cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -401610000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 0.00
BLDR cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 2719000.00
BLDR income_statement (quarterly, 2025-06-30) — Selling General And Administration: 987754000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Share Issued: 110537000.00
BLDR cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 16160000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 4178092000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -1073172000.00
BLDR income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
BLDR income_statement (quarterly, 2025-06-30) — Tax Provision: 54268000.00
BLDR income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.23
BLDR balance_sheet (quarterly, 2025-06-30) — Total Assets: 11464555000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 8848075000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Total Debt: 5314511000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 4178092000.00
BLDR income_statement (quarterly, 2025-06-30) — Total Expenses: 3922777000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 7286463000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 8176938000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 5451832000.00
BLDR income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 311287000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 71326000.00
BLDR balance_sheet (quarterly, 2025-06-30) — Working Capital: 1452986000.00
BLDR income_statement (quarterly, 2025-09-30) — +Operating Expense: 970715000.00
BLDR income_statement (quarterly, 2025-09-30) — +Total Revenue: 3941190000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 960870000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 1254739000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 4192699000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -43203000.00
BLDR income_statement (quarterly, 2025-09-30) — Basic Average Shares: 110547000.00
BLDR income_statement (quarterly, 2025-09-30) — Basic EPS: 1.11
BLDR cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 87020000.00
BLDR cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -85818000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 638183000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Capital Stock: 1106000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 296162000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 296162000.00
BLDR cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -236087000.00
BLDR cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -102495000.00
BLDR cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 547724000.00
BLDR cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -49357000.00
BLDR cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 50164000.00
BLDR cash_flow (quarterly, 2025-09-30) — Change In Inventory: 134085000.00
BLDR cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 9706000.00
BLDR cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 855000.00
BLDR cash_flow (quarterly, 2025-09-30) — Change In Payable: -49357000.00
BLDR cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 807000.00
BLDR cash_flow (quarterly, 2025-09-30) — Change In Receivables: 59621000.00
BLDR cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 205074000.00
BLDR cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 44098000.00
BLDR cash_flow (quarterly, 2025-09-30) — Changes In Cash: 209142000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Common Stock: 1106000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 4316189000.00
BLDR cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -1000.00
BLDR income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 2741707000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 407573000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Current Assets: 3296188000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 107019000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Current Debt: 14228000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 121247000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 184197000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 184197000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 1845082000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Current Provisions: 96288000.00
BLDR cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 56243000.00
BLDR cash_flow (quarterly, 2025-09-30) — Deferred Tax: 56243000.00
BLDR cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 147535000.00
BLDR cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 147535000.00
BLDR income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 110930000.00
BLDR income_statement (quarterly, 2025-09-30) — Diluted EPS: 1.10
BLDR income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 122384000.00
BLDR income_statement (quarterly, 2025-09-30) — EBIT: 228768000.00
BLDR income_statement (quarterly, 2025-09-30) — EBITDA: 376303000.00
BLDR cash_flow (quarterly, 2025-09-30) — End Cash Position: 296162000.00
BLDR cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -236087000.00
BLDR cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 461906000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Goodwill: 3996476000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 5192344000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 1297942000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Gross PPE: 2807949000.00
BLDR income_statement (quarterly, 2025-09-30) — Gross Profit: 1199483000.00
BLDR cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 10715000.00
BLDR income_statement (quarterly, 2025-09-30) — Interest Expense: 69258000.00
BLDR income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 69258000.00
BLDR cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 80539000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Interest Payable: 51496000.00
BLDR balance_sheet (quarterly, 2025-09-30) — Inventory: 1176429000.00